000 | 01336 a2200349 4500 | ||
---|---|---|---|
005 | 20250513223914.0 | ||
264 | 0 | _c20031021 | |
008 | 200310s 0 0 eng d | ||
022 | _a1522-8037 | ||
024 | 7 |
_a10.1007/s11894-000-0013-0 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aThomson, A B | |
245 | 0 | 0 |
_aAre the orally administered proton pump inhibitors equivalent? A comparison of lansoprazole, omeprazole, pantoprazole, and rabeprazole. _h[electronic resource] |
260 |
_bCurrent gastroenterology reports _cDec 2000 |
||
300 |
_a482-93 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Review | ||
650 | 0 | 4 | _a2-Pyridinylmethylsulfinylbenzimidazoles |
650 | 0 | 4 |
_aAnti-Ulcer Agents _xpharmacology |
650 | 0 | 4 |
_aBenzimidazoles _xpharmacology |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 |
_aDuodenal Ulcer _xdrug therapy |
650 | 0 | 4 |
_aGastroesophageal Reflux _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLansoprazole |
650 | 0 | 4 |
_aOmeprazole _xanalogs & derivatives |
650 | 0 | 4 | _aPantoprazole |
650 | 0 | 4 | _aProton Pump Inhibitors |
650 | 0 | 4 | _aRabeprazole |
650 | 0 | 4 |
_aSulfoxides _xpharmacology |
773 | 0 |
_tCurrent gastroenterology reports _gvol. 2 _gno. 6 _gp. 482-93 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11894-000-0013-0 _zAvailable from publisher's website |
999 |
_c11020757 _d11020757 |